当前位置: 首页 > 期刊 > 《医学信息》 > 202010
编号:13497965
米拉贝隆治疗膀胱过度活动症的有效性和安全性的Meta分析(4)
http://www.100md.com 2020年3月12日 《医学信息》 202010
     [7]Abrams P,Kelleher C,Staskin D,et al.Combination treatment with mirabegron and solifenacin in patients with overactive bladder:efficacy and safety results from a randomised,double blind,dose-ranging,phase 2 study(Symphony)[J].Eur Urol,2015,67(3):577-588.

    [8]Batista JE,Kolbl H,Herschorn S,et al.The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy:results of a noninferiority ......
上一页1 2 3 4

您现在查看是摘要页,全文长 3201 字符